Kingdon Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-150,900
Closed -$11.1M 127
2016
Q4
$11.1M Buy
150,900
+50,100
+50% +$3.73M 0.54% 60
2016
Q3
$8.09M Buy
100,800
+800
+0.8% +$64K 0.37% 65
2016
Q2
$7.88M Buy
+100,000
New +$7.53M 0.43% 60
2013
Q3
Sell
-200,000
Closed -$9.82M 207
2013
Q2
$9.82M Buy
+200,000
New +$10.9M 0.58% 48

Other funds holding LLY

Kingdon Capital Management's LLY Position: Q4 2015 in Review

Kingdon Capital Management sold out of Eli Lilly (LLY) in Q4 2015, closing a stake of 61,100 shares — an estimated $5.11M sold.

Kingdon Capital Management first reported a position in LLY in Q3 2015 and held it in 1 quarter. The position peaked at $5.11M in Q3 2015. 1,221 funds tracked by Wall St. Rank hold LLY as of Q4 2015.

  • Kingdon Capital Management reported no remaining Eli Lilly position as of Q4 2015 after selling out during the quarter.
  • Kingdon Capital Management sold 61,100 Eli Lilly shares in Q4 2015, an estimated $5.11M.
  • Kingdon Capital Management first reported a position in Eli Lilly in Q3 2015 and held it in 1 quarter.
  • Kingdon Capital Management's Eli Lilly position peaked at $5.11M in Q3 2015.
  • 1,221 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2015.

Based on Kingdon Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.